Actively Recruiting
Prevalence of Amyloidosis in Trauma Patients
Led by Consorci Sanitari de l'Alt Penedès i Garraf · Updated on 2025-12-02
246
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
CONDITIONS
Official Title
Prevalence of Amyloidosis in Trauma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women on the waiting list for scheduled trauma surgery with at least one red flag: age over 65 years; possible family history of amyloidosis; cardiac conditions including aortic stenosis, left ventricular hypertrophy (interventricular septal thickness > 12mm), history of brady- or tachyarrhythmias, cardiac conduction blocks, syncope or presyncope, or pro BNP > 300 in previous blood tests
- History of sensory peripheral neuropathy
- History of nephropathy without a clear cause
- History of liver disease without a clear cause
- Ability to cooperate with necessary evaluations
- Signed informed consent by participant or legal representative
You will not qualify if you...
- Previous diagnosis of amyloidosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil
Sant Pere de Ribes, Barcelona, Spain, 08810
Actively Recruiting
Research Team
L
Lidia Tikhomirova, MD
CONTACT
N
Noemí Casaponsa
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here